Intravenous Proton Pump Inhibitor Dosing
For high-risk upper gastrointestinal bleeding after endoscopic hemostasis, administer an 80 mg IV bolus of a proton pump inhibitor followed by continuous infusion at 8 mg/hour for 72 hours. This represents the gold-standard regimen supported by the strongest guideline evidence 1, 2.
Clinical Context and Indications
The high-dose continuous infusion regimen is specifically indicated for patients with:
- High-risk endoscopic stigmata (active bleeding, nonbleeding visible vessels, or adherent clots)
- After successful endoscopic hemostasis
This intensive regimen achieves profound acid suppression (gastric pH >6.0), which optimizes clot stability and reduces rebleeding risk 3.
Standard Dosing Regimen
The evidence-based protocol is:
- Initial bolus: 80 mg IV push
- Continuous infusion: 8 mg/hour for 72 hours
- Transition: After 72 hours, switch to oral PPI 40 mg twice daily through day 14, then once daily thereafter 2
This applies to omeprazole or pantoprazole as these are the agents studied in the pivotal trials 1.
Alternative Dosing: Intermittent Regimen
Recent evidence suggests intermittent dosing may be non-inferior to continuous infusion. A 2014 meta-analysis demonstrated that intermittent PPI therapy (40 mg IV bolus daily) produces comparable rebleeding rates to the continuous infusion regimen, with an absolute risk difference of -2.64% (well below the 3% non-inferiority margin) 4.
Individual studies support this finding:
- Standard-dose regimen (40 mg daily bolus) showed similar rebleeding rates (8.1%) compared to intensive regimen (11.8%) 5
- Another trial found no statistical difference between high-dose and standard-dose regimens (6.2% vs 5.2% rebleeding) 6
However, guidelines have not yet been updated to reflect this newer evidence, and the 80 mg bolus + 8 mg/hour infusion remains the official recommendation 1, 2.
Pre-Endoscopy Management
For patients awaiting endoscopy, high-dose PPI therapy should be initiated empirically, though the evidence is less robust (Grade C recommendation) 1. The rationale is biological plausibility and the excellent safety profile of PPIs.
Stress Ulcer Prophylaxis in ICU
For critically ill adults requiring stress ulcer prophylaxis, low-dose regimens are appropriate - not the high-dose continuous infusion 7. Standard prophylactic dosing (e.g., pantoprazole 40 mg daily or omeprazole 20 mg daily) is sufficient for prevention in this context.
Key Caveats
- The continuous infusion regimen is NOT a substitute for endoscopic hemostasis - it is adjunctive therapy after successful endoscopic treatment 1
- Class effect: While omeprazole and pantoprazole have the most robust data, this is considered a class effect applicable to all PPIs 1
- Route matters for acute bleeding: IV administration is essential initially because oral absorption may be impaired in acute bleeding states
- Discontinue when appropriate: Once the acute bleeding episode resolves and risk factors are no longer present, de-escalate or discontinue PPI therapy to avoid unnecessary long-term use 7
Practical Algorithm
For acute upper GI bleeding:
- Start 80 mg IV bolus immediately
- Begin 8 mg/hour continuous infusion
- Perform endoscopy within 24 hours 2
- If high-risk stigmata found → continue infusion for full 72 hours
- Transition to oral PPI 40 mg BID on day 4
- Continue BID dosing through day 14, then once daily
For stress ulcer prophylaxis in ICU:
- Use standard prophylactic doses (pantoprazole 40 mg IV daily or equivalent)
- Discontinue before ICU transfer to prevent inappropriate continuation 7
The evidence strongly supports the high-dose continuous infusion regimen for high-risk bleeding, though emerging data suggest intermittent dosing may be adequate and more practical in resource-limited settings 4, 5, 6.